ivabradine has been researched along with Tachycardia in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (12.50) | 29.6817 |
| 2010's | 22 (55.00) | 24.3611 |
| 2020's | 13 (32.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bertero, A; Cain, K; Dupras, S; El-Nachef, D; Futakuchi-Tsuchida, A; Jayabalu, A; Kalucki, FA; Kattman, S; Knollmann, BC; MacLellan, WR; Marchianò, S; Murry, CE; Nakamura, DS; Nakamura, K; Neidig, LE; Pabon, L; Reinecke, H; Robinson, MR; Thies, RS; Tian, R; Tsuchida, H; Weber, GJ; Whittington, D; Yang, X | 1 |
| He, R; Liu, Y; She, F; Xie, Y; Zhang, P; Zhao, L | 1 |
| Almorad, A; Bala, G; Beaver, TM; Brodt, CR; Brugada, P; Chierchia, GB; de Asmundis, C; Gauthey, A; La Meir, M; Lakkireddy, D; Lee, RJ; Monaco, C; Olshansky, B; Overeinder, I; Pannone, L; Sieira, J; Sorgente, A; Ströker, E | 1 |
| Gao, W; Guo, Y; Huang, M; Li, F; Liu, T; Xu, X | 1 |
| Karadeniz, C; Tasci, O | 1 |
| Arrotti, S; Boriani, G; Coppi, F; Monopoli, DE; Rossi, R; Sgura, FA; Talarico, M | 1 |
| Bonadei, I; Carubelli, V; Dallapellegrina, L; Sciatti, E; Vizzardi, E | 1 |
| Chokhandre, M; Dharod, D; Joshi, S; Khan, N; Mandrekar, A; Salvi, P | 1 |
| Ames, WA; Machovec, KA | 1 |
| Imamura, T | 1 |
| Carrara, M; Ferrario, M; Herpain, A; Niccolo, A | 1 |
| Carrara, M; Ferrario, M; Herpain, A | 1 |
| Chang, HY; Chen, CH; Lan, WR; Lee, YH; Liao, FC; Lin, SI; Liu, PY; Tsai, CT; Wu, YJ | 1 |
| Aravindan, A; Datta, PK; Parakh, N; Ramachandran, R; Ray, BR; Rewari, V; Seth, S; Singh, PM; Trikha, A | 1 |
| Hayat, S; Li Kam Wa, ME; Lim, PB; Taraborrelli, P | 1 |
| Brofferio, A; Lin, F; Malaza, G; Pacak, K | 1 |
| Brunelli, C; Scagliola, R | 1 |
| Brofferio, A; Malaza, G; Pacak, K | 1 |
| Busseuil, D; Davy, JM; Lattuca, B; Leclercq, F; Rhéaume, E; Roubille, F; Tardif, JC | 1 |
| Goicolea, J; Hamon, M; Lopez-de-Sà, E; Lopez-Sendon, JL; Meinertz, T; Schiele, F; Steg, P; Werdan, K | 1 |
| Bemelmans, RH; Visseren, FL | 1 |
| Kositsyna, IV; Tereshchenko, SN; Uskach, TM | 1 |
| Garganeeva, AA; Shabanova, MV | 1 |
| Ebelt, H; Frantz, S; Geißler, I; Gekle, M; Grossmann, C; Hoffmann, S; Klöckner, U; Korth, H; Li, Y; Loppnow, H; Müller-Werdan, U; Otto, V; Ruccius, S; Rueckschloss, U; Stieber, J; Werdan, K; Zhang, Y | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Naesheim, T; Torgersen Engstad, E | 1 |
| Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M | 1 |
| Böhm, M; Reil, JC | 1 |
| Bugatti, S; Dei Cas, L; Lombardi, C; Metra, M; Zacà, V | 1 |
| Becker, M; Koch, KC; Lepper, W; Westenfeld, R; Zwicker, C | 1 |
| De Santis, V; Fontana, A; Guarracino, F; Pellegrini, F; Tritapepe, L; Vitale, D | 1 |
| Heusch, G | 1 |
| Frith, J; McDonald, C; Newton, JL | 1 |
| Salukhe, T; Sutton, R | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Heidenreich, PA; Kapoor, JR | 1 |
| Becher, PM; Lindner, D; Miteva, K; Savvatis, K; Schmack, B; Schultheiss, HP; Tschöpe, C; Van Linthout, S; Westermann, D; Zietsch, C | 1 |
| Chilton, RJ; Lindsey, ML; Ma, Y | 1 |
| Hennersdorf, MG | 1 |
| Celik, S; Dengler, TJ; Doesch, AO; Ehlermann, P; Frankenstein, L; Katus, HA; Koch, A; Zehelein, J | 1 |
| Baumhäkel, M; Böhm, M; Custodis, F; Gensch, C; Laufs, U; List, F; Schlimmer, N | 1 |
9 review(s) available for ivabradine and Tachycardia
| Article | Year |
|---|---|
Targeted Treatment of Inappropriate Sinoatrial Node Tachycardia Based on Electrophysiological and Structural Mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Tachycardia; Tachycardia, Sinus | 2022 |
The role of heart rate and ivabradine in acute heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiovascular Agents; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Myocardial Contraction; Patient Discharge; Prognosis; Tachycardia | 2019 |
Use of Ivabradine in the Treatment of Tachyarrhythmias After Surgery for Congenital Heart Diseases.
Topics: Benzazepines; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Ivabradine; Tachycardia | 2020 |
Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
Topics: Cardiovascular Agents; Digoxin; Heart Failure; Heart Rate; Humans; Ivabradine; Stroke Volume; Tachycardia | 2021 |
[The resting heart rate].
Topics: Benzazepines; Blood Pressure; Cardiovascular Diseases; Heart Failure; Heart Rate; Humans; Ivabradine; Prognosis; Risk Factors; Tachycardia | 2014 |
[Ivabradine in acute myocardial infarction].
Topics: Anti-Arrhythmia Agents; Benzazepines; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Myocardial Infarction; Tachycardia; Treatment Outcome | 2014 |
[Heart rate: a risk factor or an epiphenomenon?].
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Benzazepines; Calcium Channel Blockers; Cohort Studies; Cyclic Nucleotide-Gated Cation Channels; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Hypertension; Ivabradine; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Stereoisomerism; Tachycardia; Time Factors; Ventricular Dysfunction, Left | 2010 |
Heart rate and heart failure. Not a simple relationship.
Topics: Animals; Benzazepines; Cardiac Pacing, Artificial; Coronary Artery Disease; Disease Models, Animal; Heart Failure; Heart Rate; Humans; Ivabradine; Models, Cardiovascular; Multicenter Studies as Topic; Myocardial Ischemia; Myocardium; Randomized Controlled Trials as Topic; Stress, Mechanical; Tachycardia; Tachycardia, Supraventricular; Treatment Outcome; Ventricular Dysfunction, Left; Vertebrates | 2011 |
Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Benzazepines; Heart Failure; Heart Rate; Humans; Ivabradine; Prognosis; Tachycardia | 2012 |
4 trial(s) available for ivabradine and Tachycardia
| Article | Year |
|---|---|
Effectiveness of enteral ivabradine for heart rate control in septic shock: A randomised controlled trial.
Topics: Heart Rate; Humans; Ivabradine; Shock, Septic; Stroke Volume; Tachycardia | 2021 |
Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Benzazepines; Double-Blind Method; Female; Heart Rate; Humans; Infusions, Intravenous; Ivabradine; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Tachycardia; Treatment Outcome | 2013 |
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
Topics: Aged; Benzazepines; Cardiovascular Diseases; Coronary Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Factors; Tachycardia; Ventricular Dysfunction, Left | 2008 |
Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
Topics: Adult; Aged; Benzazepines; Calcium Channel Blockers; Cardiotonic Agents; Cyclic Nucleotide-Gated Cation Channels; Exercise Tolerance; Female; Heart Rate; Heart Transplantation; Humans; Ivabradine; Male; Middle Aged; Tachycardia | 2007 |
27 other study(ies) available for ivabradine and Tachycardia
| Article | Year |
|---|---|
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based Therapy; Disease Models, Animal; Drug Combinations; Humans; Ivabradine; Male; Myocardial Infarction; Myocytes, Cardiac; Pluripotent Stem Cells; Stem Cell Transplantation; Swine; Tachycardia | 2021 |
Report of a patient with refractory atrial tachycardia whose heart rate was controlled using ivabradine.
Topics: Aged, 80 and over; Catheter Ablation; Female; Heart Rate; Humans; Ivabradine; Tachycardia; Tachycardia, Supraventricular | 2022 |
Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Female; Humans; Ivabradine; Stroke Volume; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
Ivabradine in a 15-day-old male neonate with refractory focal atrial tachycardia.
Topics: Child; Electrocardiography; Humans; Infant, Newborn; Ivabradine; Male; Tachycardia; Tachycardia, Ectopic Atrial; Tachycardia, Ectopic Junctional; Tachycardia, Supraventricular | 2023 |
Effects of Ivabradine on Right Ventricular Systolic Function in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale.
Topics: Aged; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Heart Disease; Quality of Life; Tachycardia; Ventricular Function, Right | 2023 |
Big Syringe, Little Syringe.
Topics: Heart Defects, Congenital; Humans; Ivabradine; Syringes; Tachycardia | 2020 |
What Is the Optimal Heart Rate Control for Atrial Tachyarrhythmia Following Cardiac Surgery?
Topics: Cardiac Surgical Procedures; Heart Defects, Congenital; Heart Rate; Humans; Ivabradine; Tachycardia | 2021 |
Reducing tachycardia in septic shock patients: do esmolol and ivabradine have a chronotropic effect only?
Topics: Animals; Humans; Ivabradine; Propanolamines; Shock, Septic; Swine; Tachycardia | 2020 |
Tachycardia control in septic shock with esmolol and ivabradine: a comparison on heart function.
Topics: Animals; Humans; Ivabradine; Propanolamines; Shock, Septic; Swine; Tachycardia | 2020 |
Respiration driven excessive sinus tachycardia treated with clonidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Benzazepines; Cardiovascular Agents; Clonidine; Cough; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Humans; Inhalation; Ivabradine; Male; Syncope; Tachycardia; Tachycardia, Sinus; Treatment Outcome | 2017 |
Ivabradine in Catecholamine-Induced Tachycardia in a Patient with Paraganglioma.
Topics: Cardiovascular Agents; Catecholamines; Humans; Ivabradine; Male; Middle Aged; Norepinephrine; Octreotide; Organometallic Compounds; Paraganglioma; Tachycardia | 2019 |
More on Ivabradine in Tachycardia with Paraganglioma.
Topics: Catecholamines; Humans; Ivabradine; Paraganglioma; Tachycardia; Tachycardia, Sinus | 2019 |
More on Ivabradine in Tachycardia with Paraganglioma. Reply.
Topics: Catecholamines; Humans; Ivabradine; Paraganglioma; Tachycardia; Tachycardia, Sinus | 2019 |
Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment?
Topics: Benzazepines; Dobutamine; Humans; Ivabradine; Models, Theoretical; Tachycardia | 2013 |
[Effect of optimal pulse slowing therapy on the course of recovery period in patients with ischemic heart disease after surgical myocardial revascularization].
Topics: Benzazepines; Bisoprolol; Cardiovascular Agents; Comparative Effectiveness Research; Drug Monitoring; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Postoperative Complications; Tachycardia; Treatment Outcome | 2014 |
Direct inhibition, but indirect sensitization of pacemaker activity to sympathetic tone by the interaction of endotoxin with HCN-channels.
Topics: Animals; Benzazepines; Heart Rate; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Lipopolysaccharides; Male; Mice; Myocytes, Cardiac; Rats; Sympathetic Nervous System; Tachycardia | 2015 |
Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
Topics: Animals; Benzazepines; Cardiac Output; Cardiotonic Agents; Coronary Circulation; Dobutamine; Energy Metabolism; Heart; Heart Rate; In Vitro Techniques; Ivabradine; Male; Mice; Myocardial Ischemia; Myocardium; Oxygen Consumption; Stroke Volume; Swine; Tachycardia; Ventricular Dysfunction, Left | 2016 |
BEAUTIFUL results--the slower, the better?
Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Disease; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Tachycardia; Ventricular Dysfunction, Left | 2008 |
Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.
Topics: Adult; Benzazepines; Cardiomyopathies; Catheterization, Swan-Ganz; Diagnosis, Differential; Female; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Syncope; Tachycardia; Treatment Outcome | 2010 |
Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery.
Topics: Aged; Benzazepines; Cardiac Output, Low; Cardiopulmonary Bypass; Catecholamines; Female; Follow-Up Studies; Humans; Ivabradine; Male; Tachycardia | 2010 |
Single centre experience of ivabradine in postural orthostatic tachycardia syndrome.
Topics: Adult; Benzazepines; Case-Control Studies; Fatigue; Female; Heart Rate; Humans; Incidence; Ivabradine; Male; Middle Aged; Orthostatic Intolerance; Retrospective Studies; Sinoatrial Node; Tachycardia; Treatment Outcome | 2011 |
Ivabradine in the treatment of orthostatic intolerance.
Topics: Benzazepines; Heart Rate; Humans; Ivabradine; Orthostatic Intolerance; Sinoatrial Node; Tachycardia; Treatment Outcome | 2011 |
Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?
Topics: Benzazepines; Clinical Trials as Topic; Heart; Heart Rate; Humans; Hypertension; Ion Channels; Ivabradine; Risk; Tachycardia | 2012 |
Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and β-receptor blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II; Animals; Apoptosis; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Failure; Heart Rate; Immunohistochemistry; In Situ Nick-End Labeling; Ivabradine; Male; Metoprolol; Mice; Mice, Inbred C57BL; Multivariate Analysis; Random Allocation; Sensitivity and Specificity; Statistics, Nonparametric; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Heart rate reduction: an old and novel candidate heart failure therapy.
Topics: Animals; Benzazepines; Heart Failure; Ivabradine; Male; Metoprolol; Tachycardia; Ventricular Dysfunction, Left | 2012 |
[Possibilities of reducing heart rate by I(f)-channel inhibitors].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Cause of Death; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography; Exercise Test; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Muscle Proteins; Myocardial Infarction; Potassium Channels; Prognosis; Randomized Controlled Trials as Topic; Sinoatrial Node; Stereoisomerism; Tachycardia | 2006 |
Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Benzazepines; Cells, Cultured; Cholesterol, Dietary; Endothelium, Vascular; Heart Rate; Ivabradine; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Tachycardia | 2008 |